# Effects of Dexmedetomidine on Cognitive Outcome and Brain Injury Markers

> **NCT03585452** · NA · COMPLETED · sponsor: **Michał Kowalczyk** · enrollment: 23 (actual)

## Conditions studied

- Cognitive Dysfunction

## Interventions

- **DRUG:** Dexmedetomidine Infusion
- **DRUG:** Propofol based general anesthesia

## Key facts

- **NCT ID:** NCT03585452
- **Lead sponsor:** Michał Kowalczyk
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-01
- **Primary completion:** 2018-12-30
- **Final completion:** 2019-03-31
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2022-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03585452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03585452, "Effects of Dexmedetomidine on Cognitive Outcome and Brain Injury Markers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03585452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*